{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:10:49Z","timestamp":1790496649966,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>The pathophysiological role of neural autoantibodies in acute psychotic disorders is receiving increased attention. However, there is still an ongoing debate, whether predominantly psychotic manifestations of autoimmune encephalitides exist that may remain undetected and, thus, untreated. Furthermore, it is discussed if such conditions can be diagnosed based on serum antibody results or if a reliable diagnosis requires additional cerebrospinal fluids (CSF) results. In this study, we screened pairs of serum and CSF samples from antipsychotic-na\u00efve individuals with first-episode schizophrenic psychosis (FEP, <jats:italic>n<\/jats:italic> = 103), clinical high risk for psychosis (CHR, <jats:italic>n<\/jats:italic> = 47), and healthy volunteers (HV, <jats:italic>n<\/jats:italic> = 40) for eight different antibodies against various antigens that have been shown to be associated with autoimmune encephalitides: N-methyl-D-aspartate receptor (NMDAR, NR1 subunits only), glutamic acid decarboxylase (GAD65), leucine-rich glioma inactivated protein 1 (LGI1), contactin-associated protein-like 2 protein (CASPR2), \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit 1, AMPAR subunit 2, \u03b3-aminobutyric acid-B receptors (GABA<jats:sub>B<\/jats:sub>R), and glycine receptors. All patients were within the norm with regards to a careful neurological examination, a magnetic resonance imaging (MRI) of the brain, an electroencephalogram (EEG), and routine blood pathology. All CSF samples were autoantibody-negative. In three serum samples of individuals with FEP, we detected low-titer CASPR2 immunoglobulin (Ig) G antibodies (\u22641:160, <jats:italic>n<\/jats:italic> = 2) and non-IgG antibodies against NMDAR (<jats:italic>n<\/jats:italic> = 1) (overall serum-autoantibody prevalence in FEP: 2.91%). However, the IgG titers were below the laboratory cut-off defined for positivity, and non-IgG antibodies are of no clinical relevance. This suggests that there were no cases of autoimmune encephalitis in our cohort. Our results highlight the importance and the high specificity of CSF analysis to reliably detect autoantibodies. They confirm the hypothesis that pure psychotic manifestations of antibody-associated autoimmune encephalitides without any additional neuropsychiatric findings are very rare. However, special attention must be paid to those presenting with atypical mental illnesses with additional neurological symptoms, evidence of clinically-significant cognitive involvement, profound sleep-wake perturbations, seizures, electroencephalographic, or magnetic resonance imaging pathologies to be able to identify cases with autoimmune-mediated psychiatric syndromes.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.654602","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T05:15:34Z","timestamp":1616735734000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers"],"prefix":"10.3389","volume":"12","author":[{"given":"Christian G.","family":"Bien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrin","family":"Rohleder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane K.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna I.","family":"Bien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Koethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Markus","family":"Leweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B2","volume-title":"Brain on Fire. My month of Madness","author":"Cahalan","year":"2012"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neurol.2017.11.004","article-title":"Autoimmune encephalitis and psychiatric disorders","volume":"174","author":"Honnorat","year":"2018","journal-title":"Rev Neurol (Paris)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00406-020-01113-2","article-title":"Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations","volume":"270","author":"Endres","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/jnnp-2018-318124","article-title":"Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1)","volume":"90","author":"Lennox","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720002895","article-title":"Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases","author":"Endres","year":"2020","journal-title":"Psychol Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fimmu.2017.00181","article-title":"Autoantibodies against the N-methyl-d-aspartate receptor subunit NR1: untangling apparent inconsistencies for clinical practice","volume":"8","author":"Ehrenreich","year":"2017","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.24233","article-title":"Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses","volume":"77","author":"Lancaster","year":"2015","journal-title":"Ann Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","article-title":"Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study","volume":"4","author":"Lennox","year":"2017","journal-title":"Lancet Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S2215-0366(17)30043-3","article-title":"Serum neuronal cell-surface antibodies in first-episode psychosis","volume":"4","author":"Leypoldt","year":"2017","journal-title":"Lancet Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"The Lancet Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00415-020-09814-3","article-title":"Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome","volume":"267","author":"Bien","year":"2020","journal-title":"J Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/7854_2019_90","article-title":"Autoantibodies and psychosis","volume":"44","author":"Kelleher","year":"2020","journal-title":"Curr Top Behav Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/wps.20706","article-title":"The revised German evidence- and consensus-based schizophrenia guideline","volume":"19","author":"Gaebel","year":"2020","journal-title":"World Psychiatry."},{"key":"B19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/wps.20822","article-title":"The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis","volume":"20","author":"Howes","year":"2021","journal-title":"World Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2010.09.012","article-title":"Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis","volume":"231","author":"Wandinger","year":"2011","journal-title":"J Neuroimmunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur J Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiat."},{"key":"B25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1192\/bjo.2018.8","article-title":"The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis","volume":"4","author":"Scott","year":"2018","journal-title":"BJPsych Open."},{"key":"B26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/jamapsychiatry.2015.0526","article-title":"Absence of N-methyl-D-aspartate receptor IgG autoantibodies in schizophrenia: the importance of cross-validation studies","volume":"72","author":"de Witte","year":"2015","journal-title":"JAMA Psychiatry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clinbiochem.2016.11.023","article-title":"Pitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies","volume":"50","author":"Gastaldi","year":"2017","journal-title":"Clin Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.clinbiochem.2016.12.012","article-title":"Letter to the editor re: \u201cPitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies\u201d accurate evaluation of anti-NMDA-R cell-based assay avoids reporting of false positive results","volume":"50","author":"Komorowski","year":"2017","journal-title":"Clin Biochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ana.24545","article-title":"The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1","volume":"79","author":"Castillo-Gomez","year":"2016","journal-title":"Ann Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S2215-0366(20)30432-6","article-title":"Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies","volume":"8","author":"Cullen","year":"2021","journal-title":"Lancet Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.biopsych.2017.06.015","article-title":"Cell- and single molecule-based methods to detect anti-N-Methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE project","volume":"82","author":"J\u00e9z\u00e9quel","year":"2017","journal-title":"Biol Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10329-0","article-title":"Comparison of N-methyl-D-aspartate receptor antibody assays using live or fixed substrates","author":"Thouin","year":"2021","journal-title":"J Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/15622975.2018.1555376","article-title":"Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment","volume":"21","author":"Steiner","year":"2020","journal-title":"World J Biol Psychiatry."},{"key":"B34","unstructured":"S3-Leitlinie Schizophrenie, AWMF-Register Nr. 038-009Langfassung, Stand2019"},{"key":"B35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamapsychiatry.2018.0190","article-title":"Association of depression and anxiety disorders with autoimmune thyroiditis: a systematic review and meta-analysis","volume":"75","author":"Siegmann","year":"2018","journal-title":"JAMA Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.654602\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T05:15:36Z","timestamp":1616735736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.654602\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":35,"alternative-id":["10.3389\/fpsyt.2021.654602"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.654602","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"article-number":"654602"}}